Conflict of Interest: R. Zielman received support for conference visits from Menarini and Allergan. I.F. de Coo received support for a conference visit from Electrocore. The other authors declare that they have no conflict of interest.
How General Practitioners Treat Migraine in Children – Evaluation of a Headache Guideline
Article first published online: 25 APR 2014
© 2014 American Headache Society
Headache: The Journal of Head and Face Pain
Volume 54, Issue 6, pages 1026–1034, June 2014
How to Cite
de Coo, I. F., de Jong, G., Zielman, R. and van den Berg, J. S.P. (2014), How General Practitioners Treat Migraine in Children – Evaluation of a Headache Guideline. Headache: The Journal of Head and Face Pain, 54: 1026–1034. doi: 10.1111/head.12345
Financial support: None.
- Issue published online: 10 JUN 2014
- Article first published online: 25 APR 2014
- pharmacological treatment;
- general practitioner;
Migraine is a common illness in children associated with a negative impact on the quality of life. In the Netherlands, treatment of migraine is commonly performed by general practitioners (GPs). The migraine guideline of the Dutch College of General Practitioners recommends inactivity and acetaminophen in patients with migraine who are younger than 18 years of age.
The aim of our study was to evaluate the pharmacological treatment of migraine in children by GPs before referral to the hospital. Our objective was to answer the following questions. First, are GPs inclined to prescribe medication not listed in the Dutch College of General Practitioners Guideline? Second, which clinical characteristics are associated with the use of medication not listed in this guideline?
In this retrospective cross-sectional study, prescribed medication and migraine characteristics were investigated in Dutch migraine patients (age <18 years), using hospital records and a paper-and-pencil questionnaire.
A total of 223 children were included. Medications not listed in the guideline were used in 41.3% of the patients before referral. In children younger than 12 years, the use of medication not listed in the guideline was associated with an older age, when compared with children who were treated according to the guideline. In the group of patients older than 11 years, the use of medication not listed in the guideline was associated with a longer history of migraine and a longer duration of the migraine attacks.
Medications not listed in the GPs guideline were used in a large portion of the patients younger than 18 years with migraine who were referred to secondary care.